CN-15 ADVERSE EFFECTS OF BEVACIZUMAB IN BRAIN TUMOR PATIENTS

BACKGROUND: Bevacizumab is humanized monoclonal antibody inhibiting angiogenesis and the only FDA approved treatment for recurrent glioblastoma. The aim of this study was to look at the occurrence of various adverse effects associated with use of bevacizumab in recurrent glioblastoma. METHODS: In th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pawar, Tushar, Ladha, Harshad, Mandel, Jacob, Gilbert, Mark, O'Brien, Barbara, Hamza, Mohamed, Armstrong, Terri
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218009/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou243.15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados